Fresenius Medical Care is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April. At this time, Fresenius Medical's Other Assets are comparatively stable compared to the past year. Property Plant Equipment is likely to gain to about 10.1 B in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 6.5 B in 2025. Key indicators impacting Fresenius Medical's financial strength include:
The financial analysis of Fresenius Medical is a critical element in measuring its lifeblood. Investors should not minimize Fresenius Medical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Cash And Equivalents
421.96 Million
Fresenius
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Average Inventory
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Average Receivables
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change To Inventory
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Dividends Paid
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Netincome
Stock Based Compensation
Change To Account Receivables
Investments
Net Borrowings
Total Cashflows From Investing Activities
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Liabilities
Common Stock Shares Outstanding
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Intangible Assets
Common Stock
Current Deferred Revenue
Other Liab
Other Assets
Long Term Debt
Preferred Stock Total Equity
Property Plant Equipment
Good Will
Short Term Investments
Net Tangible Assets
Long Term Investments
Short Long Term Debt
Treasury Stock
Deferred Long Term Liab
Long Term Debt Total
Capital Surpluse
Capital Lease Obligations
Non Current Liabilities Other
Net Invested Capital
Cash And Equivalents
Net Working Capital
Capital Stock
Interest Expense
Total Revenue
Gross Profit
Operating Income
Ebit
Ebitda
Income Tax Expense
Depreciation And Amortization
Selling General Administrative
Other Operating Expenses
Research Development
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income Applicable To Common Shares
Minority Interest
Net Income From Continuing Ops
Tax Provision
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Fresenius Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Fresenius Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Fresenius Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Fresenius Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Fresenius Medical Care. Check Fresenius Medical's Beneish M Score to see the likelihood of Fresenius Medical's management manipulating its earnings.
Fresenius Medical Stock Summary
Fresenius Medical competes with Universal Health, Addus HomeCare, HCA Holdings, Tenet Healthcare, and Select Medical. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Medical is traded on New York Stock Exchange in the United States.
The reason investors look at the income statement is to determine what Fresenius Medical's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Fresenius Medical's current stock value. Our valuation model uses many indicators to compare Fresenius Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fresenius Medical competition to find correlations between indicators driving Fresenius Medical's intrinsic value. More Info.
Fresenius Medical Care is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.59 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Fresenius Medical Care is roughly 1.70 . At this time, Fresenius Medical's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Fresenius Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Fresenius Medical Care Systematic Risk
Fresenius Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Fresenius Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Fresenius Medical Care correlated with the market. If Beta is less than 0 Fresenius Medical generally moves in the opposite direction as compared to the market. If Fresenius Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Fresenius Medical Care is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Fresenius Medical is generally in the same direction as the market. If Beta > 1 Fresenius Medical moves generally in the same direction as, but more than the movement of the benchmark.
Fresenius Medical Thematic Clasifications
Fresenius Medical Care is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Fresenius Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Fresenius Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Fresenius Medical growth as a starting point in their analysis.
Fresenius Medical March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Fresenius Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Fresenius Medical Care. We use our internally-developed statistical techniques to arrive at the intrinsic value of Fresenius Medical Care based on widely used predictive technical indicators. In general, we focus on analyzing Fresenius Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Fresenius Medical's daily price indicators and compare them against related drivers.
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.